LY517717: Clinical Trials

1 trial of LY517717, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow LY517717: new trials by email Literature Review of LY517717 trials Research Report on LY517717

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery
LY517717, enoxaparin - Total Knee Replacement, Total Hip Replacement
Phase 2CompletedEli Lilly and Company5112003-12-012008-03-31

Sponsors

Eli Lilly and Company (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)